Quick answers
- What is Atacand Hct?
- Atacand Hct is a brand name of Candesartan cilexetil and hydrochlorothiazide, a prescription medicine. The FDA NDC Directory lists 3 Atacand Hct products in 3 strengths and forms.
- Who makes Atacand Hct?
- Ani Pharms holds the FDA application for Atacand Hct (NDA021093, approved September 5, 2000).
- Is there a generic or store brand of Atacand Hct?
- Yes. The FDA NDC Directory lists 13 other products with the same active ingredients, strength and form as a Atacand Hct product, 13 of them generic. Ask your pharmacist whether one is right for you.
- Has Atacand Hct been recalled?
- No recall linked to Atacand Hct products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Atacand Hct is
Each Atacand Hct product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Candesartan cilexetil and hydrochlorothiazide · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| candesartan cilexetil 16 mg · hydrochlorothiazide 12.5 mg tablet (oral) | Atacand Hct | 5 products, 5 companies | DailyMed |
| candesartan cilexetil 32 mg · hydrochlorothiazide 12.5 mg tablet (oral) | Atacand Hct | 4 products, 4 companies | DailyMed |
| candesartan cilexetil 32 mg · hydrochlorothiazide 25 mg tablet (oral) | Atacand Hct | 4 products, 4 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Candesartan cilexetil and hydrochlorothiazide →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA021093 | Ani Pharms | September 5, 2000 | 3 |
Companies that list Atacand Hct
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Atacand Hct products.
- ANI Pharmaceuticals, Inc.3 products
Recalls
No recall linked to Atacand Hct products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.